Blog

November 23, 2017April 24, 2018

Essilor’s Employee Shareholding Jumps from 20% to over 50%

Charenton-le-Pont, France – Essilor announces that employee shareholding worldwide is set to surpass 50%, exceeding the goal of 35% that had initially been set for 2020. With a record subscription by international employees to the Group’s latest plan, the number of employees with a financial participation in the company rises to over 35,000.

The Company launched a new International Employee Shareholding Plan in September 2017 to consolidate and further expand employees’ involvement in the Group’s continuous growth story. 68% of employees in 14 key countries outside France1 have subscribed to the plan, bringing the percentage of employee shareholders to over 50% worldwide by November 30th2, compared to 21% in 2016.

Employee shareholding has been integral to Essilor’s history, culture and business model for over 170 years. It is key to both the Group’s long-term success and sustainability thanks to the alignment of employees’ individual interests with the company’s Mission and strategy. In addition, employee shareholders enjoy the opportunity to contribute to a unique governance that encourages employees’ participation in Essilor’s decision-making process.

Click HERE for the full press release.

November 22, 2017April 24, 2018

One Frame Exemplifies Both Sport and Style

NIKE 5001 is a lightweight frame designed for comfort and durability. Openings in the temple arms prevent fogging and moisture accumulation. Integrated cam hinges snap firmly into place, great for all sport addicts.

www.marchon.com

November 22, 2017April 24, 2018

CNIB Offers Condolences on the Passing of Senator Tobias Enverga

CNIB offers condolences to Rosemer Enverga and her three daughters on the passing of Senator Tobias Enverga.

Senator Enverga was an advocate for those with sight loss. He was deeply committed to those who are blind and partially sighted, and this was the first charitable cause he championed when he immigrated to Canada. (Senate Hansard, June 8, 2016)

It was because of this passion that Senator Enverga supported important legislation that made a positive difference in the lives of individuals who are blind, partially sighted and print disabled in Canada and around the world.

Senator Enverga worked to pass Bill C-11, An Act to amend the Copyright Act (access to copyrighted works or other subject-matter for persons with perceptual disabilities), which ratified the Marrakesh Treaty. By helping to pass this important legislation, Canada now exports accessible books to other Marrakesh Treaty signatory countries in an effort to increase the percentage of accessible books available worldwide. Currently, approximately 7% of all literature is available to Canadians with sight loss or have a print disability. This number shrinks to just under 1% in developing nations. Senator Enverga’s dedication to advocating for people with sight loss and helping to increase the number of accessible books will never be forgotten.

Again, on behalf of CNIB clients/participants, staff and volunteers, CNIB clients/participants, staff and volunteers, we offer our sincerest condolences to the family of Tobias Enverga, his friends and Parliamentary colleagues.

Source: CNIB

November 22, 2017April 24, 2018

Labtician Ophthalmics and Laboratoires Théa Announce Joint Venture

Labtician Ophthalmics Inc. of Oakville, Canada, and Laboratoires Théa of Clermont-Ferrand, France, today announced the launch of Labtician Théa, Canada’s new leader in the preservative-free management of glaucoma, dry eye disease and lid hygiene.

Though Labtician Théa is new to Canada, a rich history of innovation runs deep within its two founding companies. Labtician Ophthalmics has 60 years of experience in bringing innovation to practice for eye care professionals in Canada. Laboratoires Théa, with 150 years of history in eye care, is now Europe’s largest family-owned ophthalmology company, having built a solid reputation as the pioneer and leader in the development of preservative-free eye care treatments.

The joint venture will leverage the strengths of both organizations to focus exclusively on helping Canadian optometrists and ophthalmologists build their practices and preserve eye health for their patients. In doing so, Labtician Théa aims to become an essential partner to Canadian optometrists and ophthalmologists, delivering solutions-focused support, backed by dedicated and experienced representatives, comprehensive education and practice management programs and highly responsive practice management specialists.

“This agreement represents a major win for Canadian eye care professionals and their patients,” says Mark Smithyes, President of Labtician Théa. He continued, “Combining Théa’s rich pipeline of preservative-free treatments, which are already the standard of care in Europe, with Labtician’s proven sales, distribution and service expertise, Canadian optometrists and ophthalmologists will now have the very best options available to improve their patients’ eye health.”

Click here for more information.

November 21, 2017April 24, 2018